Background: Ovarian tumors are one of the most common women cancers. The high vascularity of malignant ovarian tumors can be assessed by the dynamic contrast enhanced MRI allowing preoperative characterization of ovarian lesions which help for planning the proper surgical management.
Introduction
OVARIAN masses are one of the leading indications for surgery in women [1] , and it involves a heterogeneous group of malignant, benign and borderline neoplasms, resulting in diagnostic challenges [2, 3] . The preoperative accurate characterization of the complex ovarian masses is crucial for defining the optimal surgical strategy and the subsequent conservative treatment feasibility [4] . However, some overlapping features among ovarian tumors are still existed. The dynamic contrast enhanced MRI (DCE-MRI) assess the tumor vascularity and perfusion, thus allowing semiquantitative analysis and more discrimination of the ovarian tumors [12] .
The aim of this study was to assess the validity of the MRI dynamic contrast enhanced semiquantitative parameters in the differentiation between malignant, borderline and benign ovarian lesions.
Material and Methods

Patients:
This prospective study was included 25 women presenting with ovarian lesions which was diagnosed by ultrasound examination, and referred from the Obstetrics & Gynecology Department to the Radiology Department, Ain Shams Hospital during the period from November 2017 till December 2018, the patients mean age was 45.36 ± 12.76 years (range from 23 to 64 years), an informed consent was obtained from all patients according to the rules of ethical committee. 3823 3824 Dynamic Contrast Enhanced MRI Semiquantitative Parameter in Ovarian Lesions Inclusion criteria: 1-Solid or complex ovarian masses.
2-Very large cystic ovarian lesion
Exclusion criteria: 1-Purely cystic ovarian lesion. 2-Contraindications to MRI or contrast media.
Study tools: 1-Preliminary ultrasound:
A preliminary pelvic ultrasound examination was done to all patients before DCE MRI to exclude simple cystic ovarian lesion. A trans abdominal and/or transvaginal ultrasound examination was performed using (LOGIQTM P7, GE Healthcare) using 3-5 and 7-10MHz probes.
2-MRI examination:
All patients underwent MRI on 1.5 T MRI Philips Achieva scanner using pelvic phased-array coil and it included conventional and dynamic contrast enhanced MRI.
The conventional MRI study involved:
• Axial T1 WI (TR=550ms, TE=24ms) and axial T2 WI (TR=7645ms, TE=115ms) with 6mm slice thickness, 1mm gap, 320-380mm field of view (FOV) and 256 x 256 matrix. • Sagittal T2 WI and coronal T2 WI with 8-10mm slice thickness, 1mm gap, 400-500mm FOV, and 256 x 256 matrix. • Axial T1 WI spectral pre-saturation inversion recovery images (TR=550ms, TE=24ms, 5mm slice thickness, 0.5-to 1.0-mm gap, 256 x192 matrix, flip angle=90º and FOV=320-380mm.
Dynamic contrast enhanced MRI:
Dynamic Post contrast T1 THRIVE (High Resolution Isotropic Volume Examination) images were obtained immediately after the gadolinium was injected at a dose of 0.1mmol/kg of body weight and rate of 1.5ml-sec followed by injection of 20ml of saline to flush the contrast. The dynamic study has consisted of 6 phases, the first one was the baseline pre contrast phase, then it was followed by contrast injection, with starting the others five phases after bolus injection, the duration of each post contrast phase was about 20-25 sec (according to selected FOV), and the duration of the whole dynamic sequence was about 2-3min. The parameters of each phase were TR=3.9ms, TE=1.78ms, 6/-1mm slice thickness, 320-380mm FOV, 10º flip angle, and 144 x 144 matrix.
After the dynamic images were obtained an axial, coronal and sagittal T1 weighted delayed post contrast images were also acquired.
Post processing techniques for DCE-MRI:
The dynamic contrast-enhanced MR images were analyzed by the aid of Philips IntelliSpace Portal Image and information management software V 9.0. (Philips Medical System Nederland B.V). A region of interest is manually drawn over the most avidly enhancing solid lesion, thick enhanced wall or enhancing septations, the time intensity curve was automatically performed, then the enhancement amplitude, as well as the initial peak of uptake, was also automatically calculated.
Data interpretation:
The morphological features of each lesion in Conventional MR were analyzed according to size, bilaterally, border, signal characteristics at T1 WI and T2 WI. Features suggestive of malignancy included: Solid mass, large solid component (>6mm) in cystic lesion, vegetations or nodularity in cystic lesion, walls and septa thickening more than 3mm, large lesion more than 6cm, necrosis, hemorrhage and regions of marked enhancement. Features of malignant tumor speed included: Pelvic and/or para aortic lymph nodes, pelvic wall infiltration, involvement of other pelvic organs, peritoneal and/or omental deposit and ascites [13] .
The post processing DCE MRI was evaluated regarding the time intensity curve (TIC), enhancement amplitude and the time of initial peak of uptake (T max ).
The time intensity curve showed three patterns: Type I which had a gradual increase in its signal intensity without a well-defined shoulder, Type II curve which had a moderate earlier rising yet the enhancement of lesion still later than that of myometrial enhancement and it was followed with plateau, and Type III which had a rapid steep rising so the curve of lesion was shifted to occur earlier than the myometrial curve and it may be followed by washout or even plateau [14] .
The enhancement amplitude of the lesion was expressed as maximum relative enhancement percentage (MRE%), and it is calculated by the equation (signal intensity after contrast injection -signal intensity before contrast injection) / baseline signal intensity pre contrast injection [15] .
The time of initial peak of uptake (T max ) and it was usually defined as early initial peak (peak occurred in the early two phases of dynamic study after contract injection), and delayed peak (peak delayed to the last phases of dynamic study).
The pathology of ovarian tumors suggested by the conventional MR examination and DCE MRI analysis, whether benign or malignant (which included malignant invasive and borderline) was correlated with the histopathological result, and in case of bilateral lesion, the more malignant looking lesion was analyzed to reduce intra-individual bias.
Statistical analysis:
The data analysis was done using computer programs SPSS (version 15 for Microsoft Windows). Data were expressed as Mean ± SD for quantitative parametric measures in addition to frequencies (number of cases) and percentages when appropriate. For comparing categorical data, X 2 test was performed. Diagnostic validity tests were used, including diagnostic sensitivity, specificity, and accuracy. p-values less than 0.05 was considered statistically significant.
Results
Twenty-five patients with a solid/complex adnexal lesion underwent DCE MRI. No adverse events occurred during the MRI examination. No statically significant difference regarding patient means age between different pathological groups, the mean age for benign lesions was 39 ± 14 years, for borderline tumor was 47 ± 12 years and for malignant tumors was 48 ± 11 years.
The histopathological result of ovarian lesions was classified into 8 benign and 17 malignant tumors (14 malignant invasive and 3 borderline tumor tumors). Benign lesions included 2 endometriomas, 2 mature cystic teratomas 2 tubo-ovarian abscesses, 1 fibrothecoma, and 1 serous cystadenoma. Borderline tumors included 1 serous cystadenofibroma, 1 mucinous cystadenoma and 1 serous cystadenoma. Malignant invasive tumors included 6 serous cystadenocarcinoma, 4 mucinous cystadenocarcinomas, 2 immature cystic teratomas, 1 dysgerminoma and 1 granulosa cell carcinoma. Table (1) .
Analysis of ovarian tumors by conventional MRI study:
17 cases were diagnosed as malignant tumors (malignant invasive and borderline tumor) by their morphological features in the conventional MRI, yet the reference histopathological results revealed that 12 of 17 were malignant invasive (TP), 2 were borderline tumors (TP) and 3 were benign lesions (FP) (1 tubo-ovarian abscess, 1 serous cystadenoma and 1 mature cystic teratoma). 8 cases were diagnosed by the conventional MRI morphological features as benign lesions, 5 of them were true benign (TN), while 3 cases were malignant and diagnosed as benign lesions (FN).
(1 immature teratoma, 1 serous cyst adenofibroma and 1 serous cystadenocarcinoma). Table (2) .
Analysis of ovarian tumors by DCE-MRI: Curve type:
The type III curve was noted in 10 cases, all of them were malignant invasive tumors yielding 100% specificity, while type I curve was noted in 8 cases; 6 were benign lesions, 1 was borderline lesion and 1 was malignant invasive tumor, lastly type II curve was seen in 7 cases with overlying distribution between benign (2 lesions), borderline (2 lesions) and malignant invasive lesions (3 lesions). Table ( 3).
The semi quantitative analysis:
The MRE% mean value of malignant invasive tumor was 135%±67 which was significantly higher than benign (75% ± 45) (p<0.001), and borderline lesions (95%±51) (p<0.002). The T m ax was significantly of shorter duration in malignant invasive tumor with mean value of 60 ± 11 sec compared to mean value of benign (150± 16 sec) (p<0.001), and borderline lesions (110 ± 13 sec) (p<0.019). No significant difference was noted in the MRE% and T ma x between the benign and borderline lesion ( p 0.775 and 0.638 respectively). Tables (4, 5) . Figs.
(1-3). The MRE% and Tmax cutoff value for differentiating malignant (invasive & borderline) and benign lesions was 128% and 65 sec respectively. The MRE% had higher sensitivity than Tmax for the differentiation between malignant ovarian tumors and benign lesions (88% sensitivity for MRE% and 85.7% sensitivity for Tmax) as well as 
Discussion
Although conventional MRI provide anatomical and morphological features of ovarian lesions through its high spatial and contrast resolution [12] , yet the conventional MRI has insufficient value for discrimination between benign and borderline tumors [10, 16] , which is clinically important, as women with borderline ovarian tumors are young with relatively better prognosis, and a conservative surgery aiming to preserve their fertility could be considered for them [17] .
Angiogenesis with the formation of new blood vessels is the cornerstone of tumor growth, progression, and invasion [18] . The malignant tumors are generally hypervascular with fragile immature vessels and increased permeability allowing the contrast agent to penetrate the interstitial space more quickly, whereas the benign tumors are most likely hypovascular having relatively mature vessels with no obvious change in tumor permeability [19] . Based on this different enhancement pattern, DCE-MRI could be used to assess the ovarian tumors microcirculatory perfusion and provide a useful tool for their discrimination through the time intensity curve (TIC) and the semiquantitative parameters [12, 14] .
Our result demonstrated that the type TIC curve was accurate for distinguishing malignant invasive ovarian tumor from benign ovarian lesion, and it demonstrated that type III TIC was not plotted in the benign ovarian lesion, yet it was detected only in the malignant invasive tumors with 100% specificity, similar result was concluded by the preliminary study done by Thomassin-Naggara et al., [14] Bernardin et al., [20] and Mansour et al., [21] as they demonstrated that type III TIC had a 100% specificity for invasive ovarian tumors.
Type II curve was seen in 7 cases in our study (28%) and it showed overlapped pathological distribution between the benign (2 cases), borderline (2 cases) and malignant invasive lesions (3 cases), Li et al., [22] also revealed that type II TIC was distributed between borderline, malignant invasive and benign lesions, and it was not specific for one of them.
Although the type I curve mostly was seen in the benign lesions, as it was seen in 6/8 (75%) of benign lesions and in 1/3 (33.3%) of borderline tumors yet the uneven distribution between borderline and benign ovarian lesions had compromised the usage of type I curve for discrimination between benign and borderline ovarian pathology, similar results was also concluded by Thomassin-Naggara et al., [14] and Pegah et al., [23] who revealed that an overlapping in type I frequency between the benign and borderline ovarian lesions, had undermined type I curve for identification of benign ovarian lesions.
To improve the diagnostic performance of DCE MRI, a semiquantitative parameter was then analyzed which in conjunction with identification of TIC type had shown an improved diagnostic accuracy.
Our study revealed that the mean value of MRE% was significantly higher for malignant invasive tumor (135%±67) than benign (75% ± 45) and borderline lesions (95% ± 51), near similar results for borderline and benign ovarian lesions were also concluded by Thomassin-Naggara et al., [14] who showed that the enhancement amplitude (which was corresponding to MRE% in our study) was 187.7%±67.7, 80.9%±43.2 and 112.1%±58.8 for malignant invasive, benign and borderline ovarian pathology respectively, yet the MRE% of malignant ovarian lesions was higher than that of our study, which was attributed to the fact that their study was involved only ovarian epithelial tumors, yet our study involved a diverse types of malignant ovarian tumors. Bernardin et al., [20] and Mansour et al., [21] also shown comparable results.
The estimated cutoff value of MRE% in our study between the benign and malignant tumors (malignant invasive and borderline) was 128% with sensitivity of 88% and specificity of 87.5%, close similar cutoff point was also concluded by Mansour et al., who revealed that MRE% cutoff value was 120%, with 88% sensitivity yet with lower specificity (71.4 % specificity), yet the cutoff value that was estimated by DeSouza et al., [24] and Thomassin-Naggara et al., [14] was lower, and they considered 114% as the MRE% cutoff between benign and malignant tumors, with sensitivity of 83% and specificity of 72%, the lower value of their study could be also attributed to that their study was limited to only the epithelial ovarian tumors.
In our study the T max mean value was significantly shorter for malignant invasive ovarian tumor (60 ± 11 sec) than borderline (110 ± 13 sec) and benign ovarian lesions (150 ± 16 sec), and the estimated T max cutoff value for malignant invasive tumors was 65 sec with maximal sensitivity of 85.7% and maximal specificity of 87.5%, similar results was concluded by Sohaib et al., [25] who revealed that early enhancement of 60 sec was seen in malignant tumors. Thomassin-Naggara et al., [14] also considered T 1/2max of 29.7 seconds to be the cutoff value for malignant invasive tumor with maximum sensitivity of 92% and specificity of 79%. Nasr et al., [26] also concluded early uptake of 75sec as cutoff point for malignant tumor, yet Mansour et al., [21] revealed that Tma x was early (≤ 120sec) in malignant ovarian tumors than in borderline and benign ovarian lesions, the differences in Tma x value in our study & other study and Mansour et al. [21] study was attributed to the more lengthy time of their dynamic study, as it was consistent of 7 post contrast phases and the whole duration of their dynamic study was about 5min and 30sec, yet our dynamic study was consisted of only 5 post contrast phases and the dynamic study duration was about 2-3min.
Thomassin-Naggara et al., [14] Bernardin et al., [20] , Li et al., [22] and Mansour et al., [21] revealed that the MRE% value was higher in borderline tumors than in benign tumors, yet our study revealed that no significant difference in the MRE% and Tmax between the borderline and benign ovarian lesions which was also concluded by recent study performed by Thomassin-Naggara et al., [27] using DCE T1 permeability parameters, and it revealed that there was no significant difference in the quantitative parameters or perfusion heterogeneity value between the borderline and benign ovarian lesions.
In our study, the MRE% showed maximal sensitivity and accuracy (92 and 88.2 respectively) for characterization of ovarian lesions as compared to Tmax (85.7 and 86.4 respectively).
The semiquantitative parameters of DCE MRI increased the accuracy of MRI examination for characterization of ovarian lesion to reach 88.2% compared to 76% of the conventional MRI, similar result was also concluded by Nasr et al., who revealed that the accuracy of conventional MRI was 73.9% and it was increased to reach 77% for the DCE MRI.
Some limitations of our study included: (1) A sizable solid tissue is needed to generate the time intensity curve and subsequent semiquantitative parameters, and so the TIC was noisy or even can't be performed in small lesions. (2) The more or less variation on the semiquantitative parameter which was attributed to the interindividual variation in the perfusion kinetic owing to variable patient physiological and physical parameter, and it could be compensated by comparing the DCE MRI semiquantitative parameters of ovarian lesions to a standard reference as uterus, or other pelvic tissue.
Conclusion:
The DCE MRI semiquantitative parameters provide numerical value which increased the accuracy and sensitivity of MRI for discrimination between malignant invasive ovarian tumors and benign & borderline ovarian lesions, so adding a role for planning the optimal surgical management, especially in young women who in need to preserve their fertility.
